Filipe Marques

Filipe Marques

Auto-generated profile, based on publicly available information

Filipe Marques

Bioengineering and Synthetic Microbiology Group, i3S- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal; Pharmazeutische Biotechnologie, Universität des Saarlandes, Campus C2.3, 66123 Saarbrücken, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Food Chemistry
Verified
Journal Article
Closed access
Iva FernandesIva Fernandes
Iva Fernandes
FMFilipe Marques
Filipe Marques
VFVitor De Freitas
Vitor De Freitas
Nuno  MateusNuno Mateus
Nuno Mateus

1 September 2018 in Metabolic Engineering
Verified
Journal Article
Closed access
LHLiliya Horbal
Liliya Horbal
FMFilipe Marques
Filipe Marques
SNSuvd Nadmid
Suvd Nadmid
MMMarta V. Mendes
Marta V. Mendes
ALAndriy Luzhetskyy
Andriy Luzhetskyy

1 November 2020 in Metabolic Engineering
Verified
Journal Article
Closed access
FMFilipe Marques
Filipe Marques
ALAndriy Luzhetskyy
Andriy Luzhetskyy
MMMarta Mendes
Marta Mendes

18 December 2015 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
FMFilipe Marques
Filipe Marques
SCSílvia Costa
Sílvia Costa
TCTania Cruz
Tania Cruz
JMJoana Moreira Marques
Joana Moreira Marques
TSTania Silva
Tania Silva
Maria Salome GomesMaria Salome Gomes
Maria Salome Gomes
Visceral leishmaniasis is a severe and potentially fatal disease caused by protozoa of the genus Leishmania, transmitted by phlebotomine sandflies. In Europe and the Mediterranean region, L. infantum is the commonest agent of visceral leishmaniasis, causing a wide spectrum of clinical manifestations, including asymptomatic carriage, cutaneous lesions and severe visceral disease. Visceral leishmaniasis is more frequent in immunocompromised individuals and data obtained in experimental models of infection have highlighted the importance of the host immune response, namely the efficient activation of host’s macrophages, in determining infection outcome. Conversely, few studies have addressed a possible contribution of parasite variability to this outcome. In this study, we compared three isolates of L. infantum regarding their capacity to grow in the organs of mice, the way they activate the host’s macrophages and other components of the immune response and also their capacity to cope with host’s antimicrobial mechanisms, namely reactive oxygen and nitrogen species. We found that the three parasite strains significantly differed regarding the degree to which they induced nitric oxide synthase (NOS2) and arginase expression in infected macrophages and the pattern of cytokine production they induced in the host, resulting in different degrees of inflammatory response in infected livers. Additionally, the three strains also significantly differed in their in vitro susceptibility to reactive oxygen and nitrogen species. This variability was reflected in the capacity of each strain to persist and proliferate in the organs of wild-type as well as NOS2- and phagocyte oxidase- deficient mice. The results obtained in this study show that parasite strain variability is an important determinant of disease outcome in L. infantum visceral leishmaniasis, with relevant implications for studies on host-pathogen interaction and also for leishmanicidal drug development.